09:22:58 EDT Sat 29 Apr 2017
Enter Symbol
or Name
USA
CA



Z:VRX - VALEANT PHARMACEUTICALS INTERNAT - http://www.valeant.com09:22:58 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VRX - Z0.19.20 · 9.440.39.25-0.13-1.49,062.979,24923,5869.40  9.49  9.2038.50  8.3119:59:29Apr 2615 min RT 2¢

Recent Trades - Last 10 of 23586
Time ETExPriceChangeVolume
19:59:29Z9.20-0.18500
19:59:29Z9.20-0.1870
19:57:52Z9.23-0.15330
19:57:09Z9.23-0.15170
19:56:15Z9.23-0.15700
19:56:15Z9.23-0.1530
19:53:10Z9.23-0.15100
19:44:48Z9.23-0.15200
19:37:10Z9.26-0.121,000
19:31:41Z9.26-0.1220

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2017-04-26 07:30U:VRXNews ReleaseBausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System
2017-04-26 07:30U:VRXNews ReleaseBausch + Lomb Receives 510(k) Clearance From FDA For Vitesse ™, The First And Only Hypersonic, Open-Port Vitrectomy System
2017-04-21 07:30U:VRXNews ReleaseValeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
2017-04-21 07:30U:VRXNews ReleaseValeant's Patient Access And Pricing Committee Announces Pricing For SILIQ ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
2017-04-10 17:00U:VRXNews ReleaseValeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call
2017-04-06 07:30U:VRXNews ReleaseBausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite™ Next-Generation Phacoemulsification Platform
2017-04-06 07:30U:VRXNews ReleaseBausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite ™ Next-Generation Phacoemulsification Platform